Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T61302 |
Anti-inflammatory agent 17
|
||
Anti-inflammatory agent 17 an orally active anti-inflammatory agent, demonstrates potent efficacy in inhibiting the release of IL-6 and TNF-α without causing cytotoxicity in in vitro experiments. Furthermore, in vivo studies confirm its anti-inflammatory activity. Given its attributes, Compound 17 holds promise for investigating Acute lung injury (ALI) [1]. |